In New South Wales, Australia, patients can legally use medical cannabis with a prescription. So far, so good. But the question that has complicated the lives of thousands of patients for years goes beyond that: what if you take your medication, get behind the wheel, get pulled over, and test positive for THC?
Can authorities suspend your license even if you’re not under the influence? Does it matter if you took your medication the night before? Is there a legal limit? Or is even a trace amount enough to get you in trouble?
That is precisely the issue the New South Wales government is now seeking to address. Chris Minns’ Labor administration announced proposed reforms to drug-driving laws so that registered medical cannabis patients are not automatically penalized for having small amounts of THC in their system.
The measure does not legalize driving under the influence of cannabis. Nor does it eliminate roadside checks. What it proposes is more specific: preventing the law from treating an impaired driver the same way it treats a patient with a prescription who has minimal traces of THC but is not necessarily impaired.
What’s Changing for Medical Cannabis Patients in New South Wales
Until now, New South Wales law has penalized the presence of THC in a person’s system, without requiring proof of actual impairment while driving. This meant that someone could have taken their medication hours earlier, driven normally, and still faced a fine or license suspension after testing positive on a saliva test.
Under the proposed reform, patients with a valid prescription would be eligible for a limited legal defense. To qualify, they must register with Transport for NSW, provide proof of their prescription, and complete an online course on cannabis and road safety.
If a registered driver tests positive on an initial saliva test, they will still face an immediate 24-hour driving ban while the sample is analyzed in a laboratory. That part would remain unchanged. Police will continue conducting roadside checks and can temporarily remove drivers who test positive from the road.
The key difference comes afterward. If the lab test shows THC levels below the proposed maximum threshold, there will be no charges or further action. According to ABC, that limit would be less than 50 nanograms per milliliter of THC in saliva.
In other words, a positive test would no longer automatically lead to a fine, suspension, or a criminal record. For patients, the system would shift from a “zero-tolerance” approach to one based on thresholds, record-keeping, and subsequent evaluation.
The Warning System: Two Strikes Before Standard Penalties
The reform also introduces a warning system. If laboratory tests show that a registered patient is above the permitted limit, they will not automatically lose their license upon the first detection. Instead, they will receive a formal warning.
The same would apply if they exceeded the threshold a second time within a two-year period. The idea, according to the government, is to allow patients to adjust their doses, schedules, or medication routines before facing harsher penalties.
However, if they test over the limit a third time within that two-year window, the standard penalties for drug driving will apply: a fine of up to AUD 704 and a minimum three-month license suspension.
The reform will not apply to everyone: holders of learner or provisional licenses, as well as commercial drivers, for instance, would be excluded. If alcohol, other drugs, or multiple substances are detected, the standard rules will still apply. And in the event of a serious crash, registered patients may be required to undergo blood or urine testing.
In other words, this is not a broad authorization to drive after using weed, but a regulated exception for patients with a valid prescription, with limits, conditions, and continued enforcement.
The Core Issue: THC Doesn’t Always Mean Impairment
At the heart of the debate lies a scientific and political question: does detectable THC in saliva necessarily mean one is unfit to drive?
Reform advocates say not necessarily. THC can remain detectable for hours, or much longer depending on the type of test, even after the psychoactive effects have worn off. For this reason, patients and legal reform organizations argue that the current system punishes residual traces, not dangerous driving.
This issue is particularly sensitive in regional areas, where driving is not a luxury but a necessity. For many patients, losing their license can mean losing their job, independence, access to healthcare, or contact with their family. Some accounts reported by Australian media describe people who stopped taking their medication out of fear of a traffic stop, even when they were using it for chronic pain, anxiety, insomnia, or PTSD.
On the other hand, the opposition and some road safety groups warn that there is still no clear consensus on which THC level reliably indicates impairment across all drivers. They argue that people react differently and that setting a specific threshold could be risky without stronger evidence on impairment.
The government is trying to find a middle ground: keep roadside checks and the 24-hour preventive driving ban in place, and penalize people who repeatedly exceed the threshold, while no longer automatically punishing patients who use a legal medication.
The reform follows a recommendation from the 2024 Drug Summit to create a medical defense for drivers who have been prescribed cannabis. Now, more than a year later, New South Wales appears to be moving toward a less punitive model, one closer to the way other prescription medications that can affect driving are treated.
The change would be reviewed after its first year of implementation. Until then, the official message is clear: this is not about freely allowing driving under the influence of cannabis, but rather about recognizing that trace THC does not always mean impaired driving.
